• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24124 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2003     Blue Cross Blue Shield Association (BCBS) Retinal nerve fiber layer analysis for the diagnosis and management of glaucoma
2014     Adelaide Health Technology Assessment (AHTA) Retinal photography with a non-mydriatic retinal camera in people with diabetes
2016     Agency for Healthcare Research and Quality (AHRQ) Retinal prostheses in the Medicare population
2016     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment
2017     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment update
2016     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC recommendation
2017     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC Recommendation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Retinal surgeries in non-hospital facilities: clinical and cost-effectiveness
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Retinal tissue transplant
1998     Health Council of the Netherlands Gezondheidsraad (GR) Retinitis pigmentosa. Assessment of a therapy
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Retreatment, switching and extended therapy with boceprevir and telaprevir for chronic hepatitis C infection: a review of the clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2005     National Institute for Health and Care Excellence (NICE) Retrobulbar irradiation for thyroid eye disease. NICE interventional procedures guidance 148
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Retrograde endovascular balloon occlusion of the aorta (REBOA)
2006     National Institute for Health and Care Excellence (NICE) Retrograde urethral sphincterometry. NICE interventional procedures guidance 167
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Retroluminal transobturatoric reposition sling for the treatment of stress urinary incontinence in men. Systematic Review
1994     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Reuse of disposable medical devices - conference
1991     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Reuse of single-use cardiac catheters
1998     Alberta Heritage Foundation for Medical Research (AHFMR) Reuse of single-use devices: electrophysiology catheters
2022     NIHR Health Technology Assessment programme REVascularisation of Ischaemic VEntricular Dysfunction (REVIVED): a randomised comparison of percutaneous coronary intervention (with optimal medical therapy) vs. optimal medical therapy alone for heart failure secondary to coronary disease
2023     Swiss Federal Office of Public Health (FOPH) Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS)
2022     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Revascularisation versus optimal medical therapy (OMT) for the treatment of chronic coronary syndrome (CCS). [Protocol]
2014     Belgian Health Care Knowledge Centre (KCE) Revascularization for lower limb peripheral arterial disease
1996     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Revascularization procedures for the treatment of stable angina pectoris: a state of the art review - nonsystematic review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Reveal Plus (TM) implantable loop recorders for the investigation of syncope and other events - horizon scanning review
2008     HAYES, Inc. Reverse shoulder total joint prosthesis
2014     HAYES, Inc. Reverse shoulder total joint prosthesis
2007     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Review of arthroplasties registers: international experiences
1998     Australian Health Technology Advisory Committee (AHTAC) Review of automated and semi-automated cervical screening devices
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for acute lymphoblastic leukaemia
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for chronic lymphocytic leukaemia
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for previously treated advanced gastric cancer
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for previously treated advanced hepatocellular carcinoma
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for previously treated multiple myeloma
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for prostate cancer
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for treating advanced urothelial carcinoma
2022     Agency for Care Effectiveness (ACE) Review of cancer drugs for treating early or advanced HER2-positive breast cancer
2006     Medical Services Advisory Committee (MSAC) Review of current practices and future directions in the diagnosis, prevention and treatment of lymphoedema in Australia: report to the Australian Health Ministers' Advisory Council February 2004
2022     Adelaide Health Technology Assessment (AHTA) Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia
2020     Health Information and Quality Authority (HIQA) Review of guidance for the operation of emergency medical dispatch centres in the context of COVID-19 and beyond
2004     NIHR Health Technology Assessment programme Review of guidelines for good practice in decision-analytic modelling in health technology assessment
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Review of Health Technology Assessment products 2003 - 2004
2003     Alberta Heritage Foundation for Medical Research (AHFMR) Review of health technology assessment skills development program
2019     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Review of immunoglobulin use for chronic inflammatory demyelinating polyneuropathy
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Review of immunoglobulin use for primary immunodeficiency diseases with antibody deficiency
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Review of immunoglobulin use for primary immunodeficiency diseases with antibody deficiency
2011     Medical Services Advisory Committee (MSAC) Review of interim funded service: Artificial intervertebral disc replacement - lumbar
2014     Medical Services Advisory Committee (MSAC) Review of interim funded service: breast Magnetic Resonance Imaging (MRI)
2011     Medical Services Advisory Committee (MSAC) Review of interim funded service: Hyperbaric Oxygen Therapy (HBOT) for the treatment of chronic non-diabetic wounds and non-neurological soft tissue radiation injuries
2011     Adelaide Health Technology Assessment (AHTA) Review of interim funded service: vertebroplasty and new review of kyphoplasty
2021     Health Information and Quality Authority (HIQA) Review of international ethics frameworks used in policy-making in the context of screening
2020     Health Information and Quality Authority (HIQA) Review of international public policy responses to easing restrictions introduced to limit the spread of COVID-19
2011     Medical Services Advisory Committee (MSAC) Review of kyphoplasty for the treatment of vertebral compression fracture and review of interim funded service: vertebroplasty for the treatment of vertebral compression fracture
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Review of luteinizing hormone-releasing hormone agonists in non-adjuvant therapy for advanced prostate cancer
1997     Australian Health Technology Advisory Committee (AHTAC) Review of magnetic resonance imaging - systematic review
1996     Australian Health Technology Advisory Committee (AHTAC) Review of magnetic resonance imaging (MRI)
2011     Adelaide Health Technology Assessment (AHTA) Review of MBS items for specific ophthalmology services under the MBS Quality Framework (Stage I)
2012     Adelaide Health Technology Assessment (AHTA) Review of MBS Items for specific ophthalmology services under the MBS Quality Framework (stage II)
2011     Medical Services Advisory Committee (MSAC) Review of MBS Items for specific ophthalmology services under the MBS Quality Framework Stage 1
2009     Health Services Assessment Collaboration (HSAC) Review of national and international clinical practice guidelines for the management of Borderline Personality Disorder: a systematic review.
2023     Health Information and Quality Authority (HIQA) Review of national public health strategies in selected countries
2024     Health Information and Quality Authority (HIQA) Review of national rare disease strategies in selected countries
2027     Belgian Health Care Knowledge Centre (KCE) Review of new oncology indications for the use of positron emission tomography (PET-scans) (Study 2024-12)
2002     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Review of non-randomised mammographic screening programmes - Systematic review
1997     Australian Health Technology Advisory Committee (AHTAC) Review of nucleic acid amplification technology
1997     Australian Health Technology Advisory Committee (AHTAC) Review of nucleic acid amplification technology - systematic review
2003     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Review of primary care interventions to improve the quality of chronic disease management. IPE-03/39 (Public report)
2021     Health Information and Quality Authority (HIQA) Review of processes in use to inform the expansion of newborn bloodspot screening programmes
2004     New Zealand Health Technology Assessment (NZHTA) Review of the effectiveness of infrared thermal imaging (thermography) for population screening and diagnostic testing of breast cancer
2006     New Zealand Health Technology Assessment (NZHTA) Review of the National Cervical Screening programme. Chapter 5: interim operational policy and quality standards 2000. Technical brief.
1995     University of York Review of the research on the effectiveness of health service interventions to reduce variations in health
1996     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Review of the scientific evidence of commercial products based on electromagnetic fields
1998     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Review of the scientific evidence of the clinical and economic implications of resistance of enterococcus to vancomycin
2009     Agency for Healthcare Research and Quality (AHRQ) Reviews of selected pharmacogenetic tests for non-cancer and cancer conditions
2014     HAYES, Inc. Revisional surgery for treatment of complications after bariatric surgery
2022     Agency for Care Effectiveness (ACE) Revivent TC transcatheter ventricular enhancement system for ischemic heart failure
2013     NIHR Horizon Scanning Centre (NIHR HSC) Revivent™ for heart failure with left ventricular scar
2015     NIHR Horizon Scanning Centre (NIHR HSC) Reza Band® for laryngopharyngeal reflux
2020     National Institute for Health and Care Excellence (NICE) Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia. NICE medical technologies guidance 49
2021     Malaysian Health Technology Assessment (MaHTAS) Rezūm therapy for management of benign prostatic hyperplasia
2000     Alberta Heritage Foundation for Medical Research (AHFMR) RF tonsillar ablation
2010     NIHR Horizon Scanning Centre (NIHR HSC) RG7204 for BRAF V600E mutation positive metastatic malignant melanoma - first or second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) RGN-259 for neurotrophic keratopathy
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rheopheresis in patients with age-related macular degeneration, sudden hearing loss or tinnitus, diabetes. Systematic review
2015     Institute of Health Economics (IHE) Rheumatoid arthritis in a policy perspective: a registry for research and better treatment of Albertans
2010     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) RhinoChill intra-nasal cooling system
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rhinochill intranasal cooling device for protective cooling the brain after a cerebral ischaemic event
2015     NIHR Horizon Scanning Centre (NIHR HSC) rhNGF for neurotrophic keratitis – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) rhPTH (Natpar) for hypoparathyroidism – adjunctive therapy
2010     Institute for Clinical and Economic Review (ICER) Rhythm control and stroke prevention strategies for patients with atrial fibrillation
2003     Institute for Clinical Systems Improvement (ICSI) Rhythm therapy versus rate control for long-term management of recurrent atrial fibrillation
2015     NIHR Horizon Scanning Centre (NIHR HSC) RhythmView™ system for cardiac arrhythmias
1999     Scottish Health Purchasing Information Centre (SHPIC) Ribavirin and interferon alfa in chronic hepatitis C - an update
2002     Scottish Health Purchasing Information Centre (SHPIC) Ribavirin and interferon alfa in the treatment of chronic hepatitis C
2000     University HealthSystem Consortium (UHC) Ribavirin/interferon alfa 2b
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ribociclib for advanced hormone receptor positive, HER2 negative breast cancer – first line
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ribociclib in combination with letrozole for the first-line therapy of HR-positive, HER2-negative recurrent or metastatic breast cancer
2017     National Institute for Health and Care Excellence (NICE) Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. NICE technology appraisal guidance 496
2021     National Institute for Health and Care Excellence (NICE) Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy. NICE technology appraisal guidance 687
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ribociclib with tamoxifen and goserelin, or a non-steroidal aromatase inhibitor and goserelin - breast cancer: advanced; hormone-receptor positive, human epidermal growth factor receptor 2 (HER2) negative; premenopausal women – first line